Patents
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
04/1993
04/15/1993WO1993007429A1 Air treatment plant for foodstuff comprising a trough with an adjustable width
04/15/1993WO1993007281A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors
04/15/1993WO1993007262A2 Purified chitin deacetylase
04/15/1993WO1993007249A1 Preparation of improved alkylpolyglycoside surfactant mixtures
04/15/1993WO1993007177A1 Method of producing starch decomposition products with a narrow molecular-weight distribution
04/15/1993WO1993007167A1 Cholesterol lowering compounds and process for making them
04/15/1993WO1993007163A1 Chemical compounds
04/15/1993WO1993007157A1 Antiviral acyclic phosphonomethoxyalkyl substituted, alkenyl and alkynyl purine and pyrimidine derivatives
04/15/1993WO1993007156A1 Naphthoquinone derivatives for the treatment of parasitic infections
04/15/1993WO1993007154A1 Process for making antimicrobial quinolonyl lactams
04/15/1993WO1993007148A1 Novel potent inducers of terminal differentiation and methods of use thereof
04/15/1993WO1993007147A1 3,9-diazabicyclo(3.3.1)nonane derivatives with 5-ht3 receptor antagonist activity
04/15/1993WO1993007146A1 Benzo and pyrido pyridazinone and pyridazinthione compounds with pde iv inhibiting activity
04/15/1993WO1993007145A1 METHOD FOR PREPARING BENZO[b]NAPHTHYRIDINES
04/15/1993WO1993007144A1 1,8-benzonaphthyridine derivatives and antimicrobial compositions
04/15/1993WO1993007143A1 Methylpiperazinoazepine derivatives, their preparation and use
04/15/1993WO1993007140A1 Heteroaryl amines as novel acetyl cholinesterase inhibitors
04/15/1993WO1993007139A1 Triazole antifungal agents
04/15/1993WO1993007137A1 Pyridinol derivatives as medicaments
04/15/1993WO1993007135A1 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl)carbamoylchroman
04/15/1993WO1993007130A1 3-ureido-benzodiazepinones useful as antagonists of cck or of gastrine
04/15/1993WO1993007128A1 Cyclic ureas and analogues useful as retroviral protease inhibitiors
04/15/1993WO1993007127A1 New derivatives of fluoro-quinoline carboxylic-3 acid and preparation thereof
04/15/1993WO1993007125A1 2-substituted quinolines for treating leishmanioses
04/15/1993WO1993007124A1 Nitrogenous heterocyclic compound
04/15/1993WO1993007123A1 Fluoroalkylated amphiphilic ligands, their metallic complexes and their uses
04/15/1993WO1993007121A1 Method of preparing a polymorphic form of terfenadine having a high melting point and high purity, and product thus obtained
04/15/1993WO1993007114A1 Oxygen substituted derivatives of nucleophile-nitric oxide adducts as nitric oxide donor prodrugs
04/15/1993WO1993007113A1 Alkoxyphenylalkylamine derivative
04/15/1993WO1993007111A1 Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity
04/15/1993WO1993007109A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phtalazineacetic acids and derivatives, preparations thereof and drugs containing same
04/15/1993WO1993006868A1 Dendrimeric polychelants
04/15/1993WO1993006866A2 Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the cd2/lfa-3 interaction
04/15/1993WO1993006860A1 Treatment of premalignant and malignant lesions
04/15/1993WO1993006852A2 Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein
04/15/1993WO1993006839A1 Method for enhancing gut absorption
04/15/1993WO1993006837A1 Process for preparing pvp-iodine product
04/15/1993WO1993006832A1 Method of treating hiv infection
04/15/1993WO1993006831A1 Use of misoprostol for the treatment of allergy
04/15/1993WO1993006830A1 N-hydroxyquinazolinone and 2-n-hydroxythiourea benzoate compounds as biocides
04/15/1993WO1993006829A1 New use of substituted quinoline carboxamide
04/15/1993WO1993006828A1 Medicament for the treatment of anxiety
04/15/1993WO1993006827A1 Topical ophthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
04/15/1993WO1993006826A1 Composition comprising s-oxiracetame for use as nootropic
04/15/1993WO1993006824A1 Preparations containing transition-metal compounds for anti-tumour therapy and/or stimulating the haematopoietic system
04/15/1993WO1993006822A1 Trimethoprim oral liquid
04/15/1993WO1993006818A1 Dermatological and/or cosmetological composition containing retinoids
04/15/1993WO1993006812A2 Use of an emulsion to prepare an intravenously administered medicament for treating skin diseases
04/15/1993WO1993006811A2 Vanadium compositions
04/15/1993WO1993006726A1 Methods for treatment of free-radical-mediated tissue injury
04/15/1993WO1993006725A1 Selective aortic arch perfusion
04/15/1993WO1993004710A3 Methods and compositions for the treatment and repair of defects or lesions in cartilage or bone
04/15/1993WO1992020328A3 Improvements in benzodiazepine treatment by cholinesterase inhibitors
04/15/1993DE4134158A1 Verwendung von wasser- oder lipidloeslichen uebergangsmetallverbindungen pharmazeutische zubereitungen und verfahren zur herstellung pharmazeutischer zubereitungen fuer die antitumortherapie und/oder stimulierung des haematopoetischen systems Use of water or lipidloeslichen by transition metal compounds pharmaceutical preparations and process for manufacture of pharmaceutical preparations for the antitumor therapy and / or stimulation of the hematopoietic system
04/15/1993DE4134156A1 9-substituierte bicyclo(3.3.0)octan-derivate, verfahren zu ihrer herstellung und ihre pharmazeutische verwendung 9-substituted bicyclo (3.3.0) octane derivatives, process for their production and their pharmaceutical use
04/15/1993DE4133694A1 Verwendung einer emulsion, zur herstellung eines arzneimittels zur iv-verabreichung zur behandlung von hauterkrankungen Use of an emulsion, for the manufacture of a medicament for intravenous administration for the treatment of skin diseases
04/15/1993DE4133366A1 Aminoacid compsn. for prevention of hypoxic cell damage - contains glycine, serine, alanine, aspartic acid or glutamic acid or mixt.
04/15/1993CA2121039A1 Use of misoprostol for the treatment of allergy
04/15/1993CA2120925A1 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
04/15/1993CA2120763A1 Dendrimeric polychelants
04/15/1993CA2120756A1 Pyridinol derivatives as medicaments
04/15/1993CA2120712A1 New use of substituted quinoline carboxamide
04/15/1993CA2120606A1 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phthalazineacetic acids and derivatives, preparations thereof and drugs containing same
04/15/1993CA2120603A1 Topical opthalmic compositions comprising 4-(3-substituted amino-2-hydroxypropoxy)-1,2,5-thiadiazoles and methods for their use
04/15/1993CA2120493A1 Process for making antimicrobial quinolonyl lactams
04/15/1993CA2120370A1 Method for genetically modifying bone marrow cells of primates, and useful cells therefor that produce recombinant retroviral vectors
04/15/1993CA2120351A1 Cyclopentane and cyclopentene derivatives with antiallergic antiinflammatory and tumor necrosis factor inhibiting activity
04/15/1993CA2120338A1 Vanadium compositions
04/15/1993CA2120328A1 Purified chitin deacetylase
04/15/1993CA2120145A1 Preparation of improved alkylpolyglycoside surfactant mixtures
04/15/1993CA2120140A1 Method of treating hiv infection
04/15/1993CA2120035A1 Benzodiazepine derivatives, their preparation and drugs containing them
04/15/1993CA2119755A1 1,8-benzonaphtyridine derivatives and antimicrobial compositions
04/15/1993CA2119656A1 Method of producing starch decomposition products with a narrow molecular-weight distribution
04/15/1993CA2118708A1 3-(n-isopropyl-n-n-propylamino)-5-(n-isopropyl) carbamoylchroman
04/15/1993CA2117179A1 Heterocyclic compounds
04/15/1993CA2116336A1 Nitrogenous heterocyclic compound
04/15/1993CA2079414A1 Heterocyclic compounds
04/14/1993EP0537070A1 Compositions containing compound TMK688 and its analogs
04/14/1993EP0537008A1 Use of biphosphonates for the manufacture of a medicament for blocking neoplastic transformation of cells induced by ras oncogenes
04/14/1993EP0537007A1 Use of formesyl-protein transferase inhibitors for the manufacture of a medicament for blocking neoplastic transformation of cells induced by ras oncogenes
04/14/1993EP0536969A2 Anti-endotoxin compounds
04/14/1993EP0536936A1 Pyrimidine nucleoside derivatives having anti-tumor activity, their preparation and use
04/14/1993EP0536896A1 Imidazolidyl macrolides having immunosuppressive activity
04/14/1993EP0536853A2 Process for the preparation of N1,N4-diethylspermine
04/14/1993EP0536843A1 Antiandrogen-5-alpha-reductase inhibitor compositions and their preparation
04/14/1993EP0536817A1 Azabicyclic compounds as tachykinin antagonists
04/14/1993EP0536713A1 Oxazole and imidazole derivatives as prostaglandin analogs
04/14/1993EP0536603A1 N-Methyl-nimodipine, process for its preparation, and its use as cerebral vasodilator
04/14/1993EP0536563A1 Nuclear inhibitor I-92 and its use for the production of a medicament
04/14/1993EP0536515A1 Novel 7-substituted-9-substituted amino-6-demethyl-6-deoxytetracyclines
04/14/1993EP0536512A1 A method and intermediates for the preparation of 6-fluorobenzisothiazoles
04/14/1993EP0536424A1 Novel benzopyran derivative
04/14/1993EP0536401A1 Tricyclo compounds, a process for their production and a pharmaceutical composition containing the same
04/14/1993EP0536400A1 Tetrazole derivative and medicine
04/14/1993EP0536361A1 $g(b)-CARBOLIN-3-HYDROXYALKYL CARBOXYLIC ACID ESTER DERIVATIVES, PROCESS FOR THEIR PRODUCTION AND THEIR USE IN MEDICAMENTS
04/14/1993EP0536360A1 Topical treatment of acne
04/14/1993EP0536316A1 Antihypercholesterolemic bis-trifluoromethyl-substituted imidazolines and derivatives thereof
04/14/1993EP0536311A1 Compositions comprising vitamin d precursors, analogs thereof and their use
04/14/1993EP0536310A1 Chemical compounds